Back to search

KAI1/CD82 expression in nonsmall cell lung carcinoma is a novel, favorable prognostic factor

Data up to Jan 2025

Published1998
Citations50
References26

Total Citations Per Year

Abstract

References (26)

KAI1 , a Metastasis Suppressor Gene for Prostate Cancer on Human Chromosome 11p11.2

1995 • 757 citations

TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins.

1990 • 365 citations

The ins and outs of the transmembrane 4 superfamily

1994 • 339 citations

Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA.

1993 • 284 citations

Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss.

1996 • 269 citations

Molecular cloning and characterization of an antigen associated with early stages of melanoma tumor progression.

1988 • 245 citations

Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer.

1996 • 193 citations

Localization of the Transmembrane 4 Superfamily (TM4SF) Member PETA-3 (CD151) in Normal Human Tissues: Comparison with CD9, CD63, and α5β1 Integrin

1997 • 190 citations

Identification of the motility-related protein (MRP-1), recognized by monoclonal antibody M31-15, which inhibits cell motility.

1991 • 189 citations

KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases.

1996 • 168 citations

Novel structurally distinct family of leucocyte surface glycoproteins including CD9, CD37, CD53 and CD63

1991 • 154 citations

C33 antigen and M38 antigen recognized by monoclonal antibodies inhibitory to syncytium formation by human T cell leukemia virus type 1 are both members of the transmembrane 4 superfamily and associate with each other and with CD4 or CD8 in T cells.

1993 • 152 citations

Motility related protein 1 (MRP-1/CD9) expression: inverse correlation with metastases in breast cancer.

1995 • 143 citations

Molecular cloning of cDNA for the human tumor-associated antigen CO-029 and identification of related transmembrane antigens.

1990 • 136 citations

Reduced motility related protein-1 (MRP-1/CD9) gene expression as a factor of poor prognosis in non-small cell lung cancer

1996 • 131 citations

An immunogenic Mr 23,000 integral membrane protein of Schistosoma mansoni worms that closely resembles a human tumor-associated antigen.

1990 • 128 citations

Identification of membrane antigen C33 recognized by monoclonal antibodies inhibitory to human T-cell leukemia virus type 1 (HTLV-1)-induced syncytium formation: altered glycosylation of C33 antigen in HTLV-1-positive T cells

1992 • 127 citations

C33 antigen recognized by monoclonal antibodies inhibitory to human T cell leukemia virus type 1-induced syncytium formation is a member of a new family of transmembrane proteins including CD9, CD37, CD53, and CD63.

1992 • 117 citations

Loss of KAI1 messenger RNA expression in both high-grade and invasive human bladder cancers.

1997 • 112 citations

KAI1, a putative marker for metastatic potential in human breast cancer

1997 • 106 citations

The primary structure of the human leukocyte antigen CD37, a species homologue of the rat MRC OX-44 antigen.

1989 • 101 citations

Expression of the KAI1 protein in benign prostatic hyperplasia and prostate cancer.

1996 • 90 citations

Expression of the neuroglandular antigen and analogues in melanoma. CD9 expression appears inversely related to metastatic potential of melanoma

1993 • 89 citations

Differential suppression of mammary and prostate cancer metastasis by human chromosomes 17 and 11.

1994 • 83 citations

A new superfamily of lymphoid and melanoma cell proteins with extensive homology to Schistosoma mansoni antigen Sm23

1991 • 82 citations

Identification and analysis of cDNA clones encoding CD53. A pan-leukocyte antigen related to membrane transport proteins.

1990 • 57 citations

Cited By (0)

No citing papers found in database

KAI1/CD82 expression in nonsmall cell lung carcinoma is a novel, favorable prognostic… (1998) – Cancer | Metascience Observatory Explorer